sftd

Pfizer's Selzentry(TM) (maraviroc), Approved by the FDA for Adult HIV Patients

Filed in archive News , Treatment on August 7, 2007

HIV_AIDS.jpg
The antiretroviral drug maraviroc -sold under the trade name Selzentry(TM) - has recently been approved by the US FDA for use in adult HIV patients.

Maraviroc is approved for use in combination with other antiretroviral drugs for the treatment of adults with CCR5-tropic HIV-1, who have been treated with other HIV medications and who have evidence of elevated levels of HIV in their blood (viral load).


HIV is the virus that causes AIDS.

A product of Pfizer, maraviroc is the first in a new class of drugs designed to slow the advancement of HIV that received FDA priority review status.

Selzentry(TM) is a novel oral HIV treatment.

Source: FDA News; Pfizer press release

[Photo Credit: spiritindia.com]

Permalink: Pfizer's Selzentry(TM) (maraviroc), Approved by the FDA for Adult HIV Patients

Tags: maraviroc  HIV  AIDS  antiretroviral  therapy  contact  contact+lenses  oasysÂ+brand 

Vote for Pfizer's Selzentry(TM) (maraviroc), Approved by the FDA for Adult HIV Patients:

  • Currently 9.25/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.25 out of 4 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
TwitterFollow us on Twitter!
Most Popular   Allergies   Alzheimer's Disease   Arthritis   Bacteria and Bacterial Infections   Best of   Blog Carnivals   Bone Health   Cancer   Cardiovascular Health   Cases   CFS   Consumer Alert   Controversies   Dental Health   Diabetes   Diagnostics   Diarrhea   Did you know   Diet   Dietary Supplements and Vitamins